From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Hemogenyx owning moron JohnR thinks Tom Winnifrith is a “scumbag” and "disgrace"battlng for team leukemia

By Tom Winnifrith | Thursday 28 November 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


As he cheerfully admits JohnR has not read any of my articles on Hemogenyx (HEMO). He thus asserts that I am short when, had he read them, he’d know that I was not. In fact he might be aware that I am never short as I think that might allow folks to suggest that my investigative journalism is somehow compromised. His claim is that I should not be short, or I guess advocating, shorting a company which claims to be tackling leukemia. Doing so makes me a “scumbag”. Au contraire.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

Time left: 20:35:53